价值大师评分 :
0
/100
1月
3月
6月
今年
1年
3年
5年
10年
15年
全部
3年:0%
药明合联 每股营运现金流（FFO for REITs）
每股营运现金流（FFO for REITs）仅适用于房地产信托投资基金。
药明合联 （HK:02268） 公司简介
一级行业：医疗保健
二级行业：医疗诊断和研究
公司网站：
公司地址：No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
公司简介：WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.
二级行业：医疗诊断和研究
公司网站：
公司地址：No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
公司简介：WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.